Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Diabetes

• Publication date

  1998-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/DIABETES.47.3.307PMID 9519733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Familial hyperinsulinism caused by an activating glucokinase mutation.

  1998cited by this paper
• Effects of altered glucokinase gene copy number on blood glucose homoeostasis.

  1997cited by this paper
• Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families

  1997cited by this paper
• Effects of Increased Glucokinase Gene Copy Number on Glucose Homeostasis and Hepatic Glucose Metabolism*

  1997cited by this paper
• Cell-specific Expression and Regulation of a Glucokinase Gene Locus Transgene*

  1997cited by this paper
• Modulation of human glucokinase intrinsic activity by SH reagents mirrors post-translational regulation of enzyme activity.

  1997cited by this paper
• Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2).

  1997cited by this paper
• Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy.

  1996cited by this paper
• Effect of a glucokinase inhibitor on energy production and insulin release in pancreatic islets.

  1996cited by this paper
• Anomeric specificity of the native and mutant forms of human beta-cell glucokinase.

  1996cited by this paper
• A Lesson in Metabolic Regulation Inspired by the Glucokinase Glucose Sensor Paradigm

  1996cited by this paper
• Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme.

  1995cited by this paper
• Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.

  1994cited by this paper
• Site-directed mutagenesis studies on the determinants of sugar specificity and cooperative behavior of human beta-cell glucokinase.

  1994cited by this paper
• Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut.

  1994cited by this paper
• Compensation in Pancreatic β-Cell Function in Subjects With Glucokinase Mutations

  1994cited by this paper
• Mechanisms of action of nonglucose insulin secretagogues.

  1994cited by this paper
• Glucokinase: structural analysis of a protein involved in susceptibility to diabetes.

  1994cited by this paper
• Short‐term control of glucokinase activity: role of a regulatory protein

  1994cited by this paper
• Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships.

  1993cited by this paper
• Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B cells.

  1993cited by this paper
• Mammalian glucokinase and its gene.

  1993cited by this paper
• Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants.

  1993cited by this paper
• Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus

  1992cited by this paper
• Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic β-Cells and Hepatocytes

  1990cited by this paper
• Glucokinase Gene Structure: Functional Implications of Molecular Genetic Studies

  1990cited by this paper
• Differential regulation of glucokinase activity in pancreatic islets and liver of the rat.

  1986cited by this paper
• The Glucokinase Glucose Sensor in Human Pancreatic Islet Tissue

  1986cited by this paper
• Radiometric oil well assay for glucokinase in microscopic structures.

  1985cited by this paper
• Regulation of glucokinase in liver.

  1976cited by this paper
• Metabolism of glucose in the islets of Langerhans.

  1968cited by this paper

• Mapping the GCK–GKRP interaction landscape using deep mutational scanning by reverse two-hybrid screening

  2026influential citation
• Glucokinase: from allosteric glucose sensing to disease variants.

  2025cites this paper
• Assessing the Rate-Dependence of the First Phase of Glucose-Stimulated Insulin Secretion: Dynamic Perifusion Studies with Isolated Human Pancreatic Islets

  2025influential citation
• CHD3 and CHD4 coordinate gene expression programs to maintain β-cell function and identity in vivo

  2025cites this paper
• Electron-density-informed effective and reliable de novo molecular design and optimization with ED2Mol

  2025cites this paper
• Assessing the Rate-Dependence of the First Phase of Glucose-Stimulated Insulin Secretion: Dynamic Perifusion Studies with Isolated Human Pancreatic Islets.

  2025influential citation
• Unique features of β‐cell metabolism are lost in type 2 diabetes

  2024cites this paper
• Neuronal glucose sensing mechanisms and circuits in the control of insulin and glucagon secretion.

  2024cites this paper
• Glucokinase (GCK) in diabetes: from molecular mechanisms to disease pathogenesis

  2024cites this paper
• GCKR and ADIPOQ gene polymorphisms in women with gestational diabetes mellitus

  2023cites this paper
• Whole Exome Sequencing Reveals Rare Variants in Genes Associated with Metabolic Disorders in Women with PCOS

  2023cites this paper
• Prevalence of GCKR rs1260326 Variant in Subjects with Obesity Associated NAFLD and T2DM: A Case-Control Study in South Punjab, Pakistan

  2023cites this paper
• Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations

  2023cites this paper
• In Silico Molecular Docking Studies of Phytocompounds From Coleus Amboinicus Against Glucokinase

  2023cites this paper
• A comparison of daily glucose fluctuation among GCK-MODY and type 2 diabetes using continuous glucose monitoring technology.

  2023cites this paper
• Differential contribution of alpha and beta cell dysfunction to impaired fasting glucose and impaired glucose tolerance

  2022cites this paper
• Why medicines work.

  2022cites this paper
• A minimal model of glucose-stimulated insulin secretion process explores factors responsible for the development of type 2 diabetes

  2022cites this paper
• Glycemic control releases regenerative potential of pancreatic beta cells blocked by severe hyperglycemia

  2022cites this paper
• Association between glucokinase regulator gene polymorphisms and serum uric acid levels in Taiwanese adolescents

  2022cites this paper
• Glucokinase diabetes in children

  2022cites this paper
• Hypoglycemia in the Toddler and Child

  2021cites this paper
• The β-cell glucose toxicity hypothesis: attractive but difficult to prove.

  2021cites this paper
• Plasma triacylglycerols are biomarkers of β-cell function in mice and humans

  2021cites this paper
• The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes

  2021influential citation
• Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual‐acting glucokinase activator

  2021cites this paper
• Overexpression of native IF1 downregulates glucose-stimulated insulin secretion by pancreatic INS-1E cells

  2020cites this paper
• Reducing Glucokinase Activity to Enhance Insulin Secretion: A Counterintuitive Theory to Preserve Cellular Function and Glucose Homeostasis

  2020cites this paper
• Cellular and systemic mechanisms for glucose sensing and homeostasis

  2020cites this paper
• Raised blood glucose due to heterozygous glucokinase gene mutation (GCK-MODY) diagnosed for the first time in pregnancy: The dilemmas and successful management – Case report and review of literature

  2020cites this paper
• The Metabolic Activity of Sparassis crispa Extract in Hepatocytes

  2020cites this paper
• GCKR common functional polymorphisms are associated with metabolic syndrome and its components: a 10-year retrospective cohort study in Iranian adults

  2020cites this paper
• Loss of the voltage-gated proton channel Hv1 decreases insulin secretion and leads to hyperglycemia and glucose intolerance in mice

  2020cites this paper
• Anti-Hyperglycemic Efficacy of Derris ovalifolia in Alloxan-Induced Diabetic Wistar Rats

  2019cites this paper
• Effect of Hepatic Organic Anion‐Transporting Polypeptide 1B Inhibition and Chronic Kidney Disease on the Pharmacokinetics of a Liver‐Targeted Glucokinase Activator: A Model‐Based Evaluation

  2019cites this paper
• Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator

  2019cites this paper
• Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator.

  2019cites this paper
• Characterization of Glucokinase Catalysis from a Pseudo-Dimeric View

  2019cites this paper
• An overview of prospective drugs for type 1 and type 2 diabetes.

  2019cites this paper
• Concentration-Dependency and Time Profile of Insulin Secretion: Dynamic Perifusion Studies With Human and Murine Islets

  2019cites this paper
• Hv1 channel supports insulin secretion in pancreatic β cells through calcium entry, depolarization and intracellular pH regulation

  2018cites this paper
• Distribution and Stimulus Secretion Coupling of Enteroendocrine Cells along the Intestinal Tract.

  2018cites this paper
• Control of pancreatic β-cell bioenergetics.

  2018cites this paper
• Association of type 2 diabetes susceptible genes GCKR, SLC30A8, and FTO polymorphisms with gestational diabetes mellitus risk: a meta-analysis

  2018cites this paper
• Oral Glucose Insulin Secretion Test for Identifying Patients with Insulin Resistance

  2018cites this paper
• Discovery of a potent glucokinase activator with a favorable liver and pancreas distribution pattern for the treatment of type 2 diabetes mellitus.

  2018cites this paper
• α-cell glucokinase suppresses glucose-regulated glucagon secretion

  2018cites this paper
• Control of pancreatic beta cell bioenergetics

  2018cites this paper
• Glucose-dependent trans-plasma membrane electron transport and p70S6k phosphorylation in skeletal muscle cells

  2018cites this paper
• Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia.

  2017cites this paper
• Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.

  2017cites this paper
• The triggering pathway to insulin secretion: Functional similarities and differences between the human and the mouse β cells and their translational relevance

  2017cites this paper
• Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus.

  2017cites this paper
• Epigenetics in formation, function, and failure of the endocrine pancreas

  2017cites this paper
• Angiotensin II Causes &bgr;‐Cell Dysfunction Through an ER Stress‐Induced Proinflammatory Response

  2017cites this paper
• The Voltage-gated Proton Channel Hv1 Is Required for Insulin Secretion in Pancreatic β Cells

  2017cites this paper
• Deficiency of Voltage-gated Proton Channel Hv1 Leads to hypoinsulinaemia, hyperglycemia and glucose intolerance in mice

  2017cites this paper
• COEXISTENCE OF THREE OSCILLATORY MODES OF INSULIN SECRETION: MATHEMATICAL MODELING AND RELEVANCE TO GLUCOSE REGULATION

  2017cites this paper
• Mechanisms and significance of brain glucose signaling in energy balance, glucose homeostasis, and food-induced reward.

  2016cites this paper
• Induction of oxidative stress, suppression of glucose-induced insulin release, ATP production, glucokinase activity, and histomorphometric changes in pancreatic islets of hypothyroid rat.

  2016cites this paper
• Genes associated with diabetes: potential for novel therapeutic targets?

  2016cites this paper
• Insulin receptor alternative splicing is regulated by insulin signaling and modulates beta cell survival

  2016cites this paper
• Pancreatic and adrenal development and function in an ovine model of polycystic ovary syndrome

  2015influential citation
• TM Effect of 1 , 25 ( OH ) 2 vitamin D 3 on glucose homeostasis and DNA damage in type 2 diabetic mice

  2015cites this paper
• Dissecting the microRNA pathway in the pancreatic β-cell during insulin resistance

  2015cites this paper
• Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation

  2015cites this paper
• Pathophysiology of Metabolic Syndrome: Part I—Influence of Adiposity and Insulin Resistance

  2015cites this paper
• Chronic Exposure to Excess Nutrients Left-shifts the Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic β-Cells*

  2015cites this paper
• Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational Analysis.

  2015cites this paper
• Comparison of the Circulating Metabolite Profile of PF-04991532, a Hepatoselective Glucokinase Activator, Across Preclinical Species and Humans: Potential Implications in Metabolites in Safety Testing Assessment

  2015cites this paper
• Discovery and Structure-Guided Optimization of Diarylmethanesulfonamide Disrupters of Glucokinase-Glucokinase Regulatory Protein (GK-GKRP) Binding: Strategic Use of a N → S (nN → σ*S-X) Interaction for Conformational Constraint.

  2015cites this paper
• Benzimidazole Derivatives as Antidiabetic Agents

  2015cites this paper
• Investigations into islet Pdx1 activity: Contribution to mature beta-cell identity and the identification and characterization of Pdx1 coregulators

  2015cites this paper
• The effect of hexarelin in streptozotocin (STZ)-induced rat model through protective actions on islet beta cells and cardiomyocytes

  2015cites this paper
• Mutations in exons 10 and 11 of human glucokinase result in conformational variations in the active site of the structure contributing to poor substrate binding – explains hyperglycemia in type 2 diabetic patients

  2015cites this paper
• Discovery of potential biomarkers in exhaled breath for diagnosis of type 2 diabetes mellitus based on GC-MS with metabolomics

  2014cites this paper
• Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus.

  2014cites this paper
• GCK Gene-Body Hypomethylation Is Associated with the Risk of Coronary Heart Disease

  2014cites this paper
• Xuezhikang Attenuated the Functional and Morphological Impairment of Pancreatic Islets in Diabetic Mice Via the Inhibition of Oxidative Stress

  2014cites this paper
• DMD060087 1926..1939

  2014cites this paper
• Common genetic variation in the glucokinase gene (GCK) is associated with type 2 diabetes and rates of carbohydrate oxidation and energy expenditure

  2014cites this paper
• Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP‐1R activation

  2014cites this paper
• Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity

  2014cites this paper
• Protein phosphatases in pancreatic islets.

  2014cites this paper
• Polymethoxy flavones do not exert an inducing effect on the biosynthesis and secretion of insulin by pancreatic β-cells.

  2014cites this paper
• Metabolites in Safety Testing Assessment in Early Clinical Development: A Case Study with a Glucokinase Activator

  2014cites this paper
• Does Disruption of Circadian Rhythms Contribute to Beta-Cell Failure in Type 2 Diabetes?

  2014cites this paper
• Çocukluk Çağinda Diyabetin Nadir Bir Nedeni: Glukokinaz Mutasyonu (MODY2)

  2014cites this paper
• Diabetogenic effects of Glucocorticoids : role of Protein Phosphatase 5 and GLP-1 receptor activation

  2014cites this paper
• Potential role of skeletal muscle glucose metabolism on the regulation of insulin secretion

  2014cites this paper
• Genetic Counseling for Diabetes Mellitus

  2014cites this paper
• Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes

  2013cites this paper
• Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia.

  2013cites this paper
• Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity

  2013cites this paper
• birth , and death

  2013cites this paper
• The Role of SIRT1 in Pancreatic Beta Cells

  2013cites this paper
• Lessons from Mouse Models of High-Fat Diet-Induced NAFLD

  2013cites this paper
• Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motif.

  2013cites this paper
• Identification of a new class of glucokinase activators through structure-based design.

  2013cites this paper
• New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism.

  2013cites this paper